Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Your watch and grocery list could predict Crohn's flares

NCT ID NCT07159776

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 41 times

Summary

This study will give 80 people with Crohn's disease or ulcerative colitis a smartwatch and a loyalty card to track their daily activity and food purchases. Researchers want to see if this data can help detect when the disease flares up. The goal is to find new ways to monitor IBD without frequent clinic visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Imelda General Hospital

    Bonheiden, 2820, Belgium

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Corsano Health Cardio watch 287-2 wearable device and Colruyt Xtra loyalty card for food data

What this could lead to

If successful, this could lead to a way to detect IBD flares early using everyday data like heart rate and grocery purchases, potentially improving disease management.

What could go wrong

This is an early observational study with only 80 participants, so results may not apply to everyone. The approach depends on consistent device wear and shopping at specific stores, which may limit real-world use.

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.